ArticleJournal of cancer research and clinical oncology2024

Metronomic cyclophosphamide for bone marrow carcinomatosis in metastatic castration-resistant prostate cancer.

Tobias Peres et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.